DE122006000066I1 - Chinuclidinderivate - Google Patents

Chinuclidinderivate

Info

Publication number: DE122006000066I1
Authority: DE; Germany
Prior art keywords: quinuclidine derivatives; quinuclidine; derivatives
Prior art date: 1991-05-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

DE1992608877

Other languages

English (en)

Other versions

DE69208877D1 (de

DE69208877T2 (de

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-31

Filing date

1992-04-28

Publication date

2007-03-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24845673&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122006000066(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-04-28 Application filed by Pfizer Inc filed Critical Pfizer Inc

2007-03-22 Publication of DE122006000066I1 publication Critical patent/DE122006000066I1/de

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DE1992608877 1991-05-31 1992-04-28 Chinuclidinderivate Pending DE122006000066I1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70840491A	1991-05-31	1991-05-31
PCT/US1992/003317 WO1992021677A1 (en)	1991-05-31	1992-04-28	bibNUCLIDINE DERIVATIVES

Publications (1)

Publication Number	Publication Date
DE122006000066I1 true DE122006000066I1 (de)	2007-03-22

Family

ID=24845673

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
DE200612000066 Active DE122006000066I2 (de)	1991-05-31	1992-04-28	Chinuclidinderivate
DE69208877T Expired - Lifetime DE69208877T2 (de)	1991-05-31	1992-04-28	Chinuclidinderivate
DE9290063U Expired - Lifetime DE9290063U1 (de)	1991-05-31	1992-04-28	Chinuclidin-Derivate
DE1992608877 Pending DE122006000066I1 (de)	1991-05-31	1992-04-28	Chinuclidinderivate

Family Applications Before (3)

Application Number	Title	Priority Date	Filing Date
DE200612000066 Active DE122006000066I2 (de)	1991-05-31	1992-04-28	Chinuclidinderivate
DE69208877T Expired - Lifetime DE69208877T2 (de)	1991-05-31	1992-04-28	Chinuclidinderivate
DE9290063U Expired - Lifetime DE9290063U1 (de)	1991-05-31	1992-04-28	Chinuclidin-Derivate

Country Status (41)

Country	Link
US (3)	US5807867A (de)
EP (1)	EP0587723B1 (de)
JP (2)	JPH0733386B2 (de)
KR (1)	KR100214905B1 (de)
CN (1)	CN1048492C (de)
AP (1)	AP299A (de)
AT (1)	ATE135006T1 (de)
AU (1)	AU657552B2 (de)
BG (1)	BG61694B1 (de)
BR (1)	BR9206073A (de)
CA (1)	CA2102179C (de)
CZ (1)	CZ281403B6 (de)
DE (4)	DE122006000066I2 (de)
DK (1)	DK0587723T3 (de)
EG (1)	EG19944A (de)
ES (1)	ES2084361T3 (de)
FI (1)	FI114475B (de)
GR (1)	GR3019687T3 (de)
GT (1)	GT199200028A (de)
HU (1)	HU217548B (de)
IE (1)	IE72473B1 (de)
IL (1)	IL102008A (de)
IS (1)	IS1611B (de)
LU (1)	LU91293I2 (de)
MA (1)	MA22539A1 (de)
MX (1)	MX9202554A (de)
NL (1)	NL300250I2 (de)
NO (2)	NO302701B1 (de)
NZ (2)	NZ270673A (de)
OA (1)	OA09867A (de)
PL (1)	PL171379B1 (de)
PT (1)	PT100546B (de)
RO (1)	RO110499B1 (de)
RU (1)	RU2103269C1 (de)
SK (1)	SK278788B6 (de)
TW (1)	TW204349B (de)
UA (1)	UA27776C2 (de)
UY (1)	UY23422A1 (de)
WO (1)	WO1992021677A1 (de)
YU (1)	YU48995B (de)
ZA (1)	ZA923942B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA27776C2 (uk) *	1991-05-31	2000-10-16	Пфайзер Інк.	Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
KR0154882B1 (ko) *	1991-06-20	1998-11-16	알렌 제이. 스피겔	질소 함유 헤테로사이클릭 화합물의 플루오로알콕시벤질아미노 유도체
US5721255A (en) *	1992-08-19	1998-02-24	Pfizer Inc.	Substituted benzylamino nitrogen containing non-aromatic heterocycles
ES2096312T3 (es) *	1992-11-12	1997-03-01	Pfizer	Derivado de quinuclidina como antagonista de la sustancia p.
US5344830A (en) *	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
JP2822274B2 (ja) *	1993-05-19	1998-11-11	ファイザー製薬株式会社	Ｐ物質拮抗剤としてのヘテロ原子置換アルキルベンジルアミノキヌクリジン類
IL109646A0 (en) *	1993-05-19	1994-08-26	Pfizer	Heteroatom substituted alkyl benzylamino-quinuclidines
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (de) *	1993-11-17	1995-10-11	Pfizer	Substanz P Antagonisten zur Behandlung oder Verhütung des sonnenbrandes.
EP0659409A3 (de) *	1993-11-23	1995-08-09	Pfizer	Substanz P Antagonisten zur Hemmung der Angiogenese.
EP0655246A1 (de) *	1993-11-30	1995-05-31	Pfizer Inc.	Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten
IL116249A (en) *	1994-12-12	2003-07-06	Pfizer	Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
PE8798A1 (es) *	1995-07-17	1998-03-02	Pfizer	Procedimiento de separacion de los enantiomeros del 1-azabiciclo[2.2.2] octan-3-amina, 2-(difenilmetil) -n- [[2-metoxi-5-(1-metiletil) fenil] metil]
TW458774B (en)	1995-10-20	2001-10-11	Pfizer	Antiemetic pharmaceutical compositions
IL123740A0 (en) *	1997-03-28	1998-10-30	Pfizer	NK-1 receptor antagonists for the treatment of delayed emesis
NZ329807A (en) *	1997-04-23	2000-07-28	Pfizer	NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
KR20010041991A (ko) *	1998-03-19	2001-05-25	다케다 야쿠힌 고교 가부시키가이샤	복소환식 화합물, 그의 제조법 및 타키키닌 수용체길항약으로서의 용도
US6387925B1 (en) *	1999-06-01	2002-05-14	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6255320B1 (en) *	1999-06-01	2001-07-03	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
US6262067B1 (en) *	1999-06-22	2001-07-17	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
CA2324116A1 (en) *	1999-10-25	2001-04-25	Susan Beth Sobolov-Jaynes	Nk-1 receptor antagonists and eletriptan for the treatment of migraine
RU2309953C2 (ru)	1999-11-03	2007-11-10	Эймр Текнолоджи, Инк.	Арил- и гетероарилзамещенные тетрагидроизохинолины, фармацевтическая композиция и способ лечения на их основе
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
IL142810A0 (en) *	2000-05-03	2002-03-10	Pfizer Prod Inc	Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
KR100821410B1 (ko)	2000-07-11	2008-04-10	에이엠알 테크놀로지, 인크.	4-페닐 치환된 테트라하이드로이소퀴놀린 및 이의치료학적 용도
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (de) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Ein NK-3 rezeptorantagonisten und ein ZNS-penetrierende NK-1 rezeptorantagonisten enthaltende Zusammensetzung zur Behandlung von Depression und Angst
PL367944A1 (en) *	2001-07-20	2005-03-07	Pfizer Products Inc.	Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
US6686507B2 (en)	2002-03-06	2004-02-03	Pfizer Inc	Purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
US6861526B2 (en) *	2002-10-16	2005-03-01	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
US20050136487A1 (en) *	2003-10-27	2005-06-23	Meyer Donald W.	Transmissible spongiform encephalopathy detection in cervids, sheep and goats
WO2005051919A1 (en) *	2003-11-26	2005-06-09	Pfizer Products Inc.	Aminopyrazole derivatives as gsk-3 inhibitors
BRPI0507325A (pt)	2004-01-30	2007-07-03	Pfizer Prod Inc	antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia
LT1713504T (lt) *	2004-01-30	2017-09-11	Zoetis Services Llc	Antimikrobinis konservantas, skirtas multi-dozinėms kompozicijoms, panaudojant beta-ciklodekstrinus, skirtas skystoms vaisto formoms
PT1713801E (pt) *	2004-02-02	2008-02-11	Pfizer Prod Inc	Processo para a preparação de 1-(2s,3s)-2-benzidril-n-(5- -terc-butil-2-metoxibenzil)-quinuclidina-3-amina
ZA200701232B (en)	2004-07-15	2008-08-27	Amr Technology Inc	Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
ES2382814T3 (es)	2005-05-17	2012-06-13	Merck Sharp & Dohme Ltd.	Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
EP1904069B1 (de)	2005-07-15	2018-06-13	Albany Molecular Research, Inc.	Aryl- und heteroarylsubstituierte tetrahydrobenzazepine und verwendung damit zur wiederaufnahmeblockierung von norepinephrin, dopamin und serotonin
US8293900B2 (en)	2005-09-29	2012-10-23	Merck Sharp & Dohme Corp	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
CA2664113C (en)	2006-09-22	2013-05-28	Merck & Co., Inc.	Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CN101190330A (zh)	2006-11-30	2008-06-04	深圳市鼎兴生物医药技术开发有限公司	胆碱酯酶在拮抗速激肽药物中的应用
BRPI0806245B1 (pt)	2007-01-10	2022-01-25	Msd Italia S.R.L.	Compostos de fórmula i e seus usos
KR20090112722A (ko)	2007-01-24	2009-10-28	글락소 그룹 리미티드	3,5-디아미노-6-(2,3-디클로로페닐)-1,2,4-트리아진 또는 ｒ(-)-2,4-디아미노-5-(2,3-디클로로페닐)-6-플루오로메틸 피리미딘 및 ｎｋ1을 포함하는 제약 조성물
CA2682727C (en)	2007-04-02	2016-03-22	Banyu Pharmaceutical Co., Ltd.	Indoledione derivative
EP2170076B1 (de)	2007-06-27	2016-05-18	Merck Sharp & Dohme Corp.	4-carboxybenzylamino-derivate als histondeacetylase-hemmer
US8598184B2 (en)	2008-03-03	2013-12-03	Tiger Pharmatech	Protein kinase inhibitors
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
CA2760837C (en)	2009-05-12	2018-04-03	Albany Molecular Research, Inc.	7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
KR20120034644A (ko)	2009-05-12	2012-04-12	알바니 몰레큘라 리써치, 인크.	아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도
CN102638982B (zh)	2009-05-12	2015-07-08	百时美施贵宝公司	(S)-7-([1,2,4]***并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉的晶型及其用途
WO2011046771A1 (en)	2009-10-14	2011-04-21	Schering Corporation	SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
WO2011163330A1 (en)	2010-06-24	2011-12-29	Merck Sharp & Dohme Corp.	Novel heterocyclic compounds as erk inhibitors
CA2805265A1 (en)	2010-08-02	2012-02-09	Merck Sharp & Dohme Corp.	Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina)
WO2012024170A2 (en)	2010-08-17	2012-02-23	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US8883801B2 (en)	2010-08-23	2014-11-11	Merck Sharp & Dohme Corp.	Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
US8946216B2 (en)	2010-09-01	2015-02-03	Merck Sharp & Dohme Corp.	Indazole derivatives useful as ERK inhibitors
EP2615916B1 (de)	2010-09-16	2017-01-04	Merck Sharp & Dohme Corp.	Kondensierte pyrazolderivate als neue erk-hemmer
WO2012058210A1 (en)	2010-10-29	2012-05-03	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
WO2012087772A1 (en)	2010-12-21	2012-06-28	Schering Corporation	Indazole derivatives useful as erk inhibitors
JP2014514321A (ja)	2011-04-21	2014-06-19	メルク・シャープ・アンド・ドーム・コーポレーション	インスリン様増殖因子１受容体阻害剤
EP2729147B1 (de)	2011-07-04	2017-09-06	IRBM - Science Park S.p.A.	Nk-1 rezeptorantagonisten zur behandlung der hornhautrevaskularisierung
US9023865B2 (en)	2011-10-27	2015-05-05	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
US20150299696A1 (en)	2012-05-02	2015-10-22	Sirna Therapeutics, Inc.	SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
WO2014052563A2 (en)	2012-09-28	2014-04-03	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
US10154988B2 (en)	2012-11-14	2018-12-18	The Johns Hopkins University	Methods and compositions for treating schizophrenia
MX363243B (es)	2012-11-28	2019-03-14	Merck Sharp & Dohme	Composiciones para tratar cáncer y usos de dichas composiciones.
RU2690663C2 (ru)	2012-12-20	2019-06-05	Мерк Шарп И Доум Корп.	Замещенные имидазопиридины в качестве ингибиторов hdm2
US9540377B2 (en)	2013-01-30	2017-01-10	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
AU2018251604B2 (en)	2017-04-10	2022-04-14	Chase Therapeutics Corporation	NK1-antagonist combination and method for treating synucleinopathies
CN106977512B (zh) *	2017-05-04	2019-01-01	海门慧聚药业有限公司	制备马罗匹坦游离碱的方法
MX2019015150A (es)	2017-06-30	2020-08-13	Chase Therapeutics Corp	Composiciones antagonistas de nk-1 y métodos para su uso en el tratamiento de la depresión.
US10947234B2 (en)	2017-11-08	2021-03-16	Merck Sharp & Dohme Corp.	PRMT5 inhibitors
RU2020131446A (ru)	2018-02-26	2022-03-28	Оспедале Сан Раффаэле С.Р.Л.	Антагонисты nk-1 для применения в лечении глазной боли
KR102102109B1 (ko) *	2018-07-10	2020-04-20	성균관대학교산학협력단	N-벤즈히드릴 퀴뉴클리딘 유도체를 포함하는 나트륨 누출 채널 억제용 조성물
WO2020033284A1 (en)	2018-08-07	2020-02-13	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP3833668A4 (de)	2018-08-07	2022-05-11	Merck Sharp & Dohme Corp.	Prmt5-inhibitoren
EP4117673A1 (de)	2020-03-11	2023-01-18	Ospedale San Raffaele S.r.l.	Behandlung von stammzellenmangel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX18467A (es) *	1988-11-23	1993-07-01	Pfizer	Agentes terapeuticos de quinuclidinas
ATE113947T1 (de) *	1990-06-01	1994-11-15	Pfizer	3-amino-2-arylchinuclidine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE4026743A1 (de) *	1990-08-24	1992-02-27	Teves Gmbh Alfred	Blockiergeschuetzte bremsanlage fuer kraftfahrzeuge
US5716965A (en) *	1991-05-22	1998-02-10	Pfizer Inc.	Substituted 3-aminoquinuclidines
UA27776C2 (uk) *	1991-05-31	2000-10-16	Пфайзер Інк.	Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
EP1082959A1 (de) *	1991-09-20	2001-03-14	Glaxo Group Limited	NK1 Antagonisten zur Behandlung von Depression
GB9218334D0 (en) *	1992-08-28	1992-10-14	Ici Plc	Heterocyclic compounds
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0655246A1 (de) *	1993-11-30	1995-05-31	Pfizer Inc.	Substanz P Antagonisten zur Behandlung von durch Helicobacter Pylori oder andere spirale Urease-positive Gram-negative Bakterien verursachten Krankheiten
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
US5990125A (en) *	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer
ES2147889T3 (es) *	1996-01-19	2000-10-01	Lonza Ag	Metodo para preparar 3-hidroxiquinuclidinol opticamente activo.

1992
- 1992-04-28 UA UA93004096A patent/UA27776C2/uk unknown
- 1992-04-28 CZ CS923906A patent/CZ281403B6/cs not_active IP Right Cessation
- 1992-04-28 KR KR1019930703649A patent/KR100214905B1/ko not_active IP Right Cessation
- 1992-04-28 AU AU19901/92A patent/AU657552B2/en not_active Expired
- 1992-04-28 RO RO93-01581A patent/RO110499B1/ro unknown
- 1992-04-28 DE DE200612000066 patent/DE122006000066I2/de active Active
- 1992-04-28 AT AT92912601T patent/ATE135006T1/de active
- 1992-04-28 DE DE69208877T patent/DE69208877T2/de not_active Expired - Lifetime
- 1992-04-28 SK SK3906-92A patent/SK278788B6/sk not_active IP Right Cessation
- 1992-04-28 DK DK92912601.9T patent/DK0587723T3/da active
- 1992-04-28 EP EP92912601A patent/EP0587723B1/de not_active Expired - Lifetime
- 1992-04-28 HU HU9303393A patent/HU217548B/hu active Protection Beyond IP Right Term
- 1992-04-28 BR BR9206073A patent/BR9206073A/pt not_active Application Discontinuation
- 1992-04-28 ES ES92912601T patent/ES2084361T3/es not_active Expired - Lifetime
- 1992-04-28 DE DE9290063U patent/DE9290063U1/de not_active Expired - Lifetime
- 1992-04-28 US US08/211,120 patent/US5807867A/en not_active Expired - Lifetime
- 1992-04-28 DE DE1992608877 patent/DE122006000066I1/de active Pending
- 1992-04-28 RU RU93058555A patent/RU2103269C1/ru active Protection Beyond IP Right Term
- 1992-04-28 WO PCT/US1992/003317 patent/WO1992021677A1/en active IP Right Grant
- 1992-04-28 JP JP5500353A patent/JPH0733386B2/ja not_active Expired - Lifetime
- 1992-04-28 PL PL92301472A patent/PL171379B1/pl unknown
- 1992-04-28 CA CA002102179A patent/CA2102179C/en not_active Expired - Lifetime
- 1992-05-05 TW TW081103509A patent/TW204349B/zh not_active IP Right Cessation
- 1992-05-11 AP APAP/P/1992/000384A patent/AP299A/en active
- 1992-05-26 UY UY23422A patent/UY23422A1/es not_active IP Right Cessation
- 1992-05-26 IL IL10200892A patent/IL102008A/en active Protection Beyond IP Right Term
- 1992-05-29 IS IS3871A patent/IS1611B/is unknown
- 1992-05-29 MX MX9202554A patent/MX9202554A/es unknown
- 1992-05-29 GT GT199200028A patent/GT199200028A/es unknown
- 1992-05-29 NZ NZ270673A patent/NZ270673A/en not_active IP Right Cessation
- 1992-05-29 NZ NZ242956A patent/NZ242956A/en not_active IP Right Cessation
- 1992-05-29 MA MA22826A patent/MA22539A1/fr unknown
- 1992-05-29 YU YU56492A patent/YU48995B/sh unknown
- 1992-05-29 PT PT100546A patent/PT100546B/pt not_active IP Right Cessation
- 1992-05-29 ZA ZA923942A patent/ZA923942B/xx unknown
- 1992-05-30 EG EG28492A patent/EG19944A/xx active
- 1992-05-30 CN CN92104129A patent/CN1048492C/zh not_active Expired - Lifetime
- 1992-07-01 IE IE921729A patent/IE72473B1/en not_active IP Right Cessation
1993
- 1993-11-26 BG BG98248A patent/BG61694B1/bg unknown
- 1993-11-29 FI FI935297A patent/FI114475B/fi not_active IP Right Cessation
- 1993-11-29 NO NO934312A patent/NO302701B1/no not_active IP Right Cessation
- 1993-11-30 OA OA60442A patent/OA09867A/en unknown
1994
- 1994-10-05 JP JP6241456A patent/JP2645225B2/ja not_active Expired - Lifetime
1995
- 1995-01-24 US US08/377,552 patent/US6222038B1/en not_active Expired - Lifetime
1996
- 1996-04-19 GR GR960401066T patent/GR3019687T3/el unknown
1997
- 1997-04-30 US US08/846,909 patent/US5939433A/en not_active Expired - Lifetime
2006
- 2006-12-06 LU LU91293C patent/LU91293I2/fr unknown
- 2006-12-06 NL NL300250C patent/NL300250I2/nl unknown
2007
- 2007-03-09 NO NO2007003C patent/NO2007003I2/no unknown

Also Published As

Publication number	Publication date
BG98248A (bg)	1994-07-29
TW204349B (de)	1993-04-21
CA2102179A1 (en)	1992-12-01
JPH07285965A (ja)	1995-10-31
PT100546A (pt)	1993-08-31
AP9200384A0 (en)	1992-07-31
YU56492A (sh)	1995-03-27
AP299A (en)	1994-01-14
AU657552B2 (en)	1995-03-16
DE69208877D1 (de)	1996-04-11
JP2645225B2 (ja)	1997-08-25
UA27776C2 (uk)	2000-10-16
EP0587723A1 (de)	1994-03-23
US5939433A (en)	1999-08-17
DE69208877T2 (de)	1996-07-25
IE72473B1 (en)	1997-04-23
CN1048492C (zh)	2000-01-19
LU91293I2 (fr)	2007-02-06
OA09867A (en)	1994-08-15
DE122006000066I2 (de)	2007-12-06
HU9303393D0 (en)	1994-03-28
EG19944A (en)	1997-02-27
NO2007003I1 (no)	2007-03-26
US6222038B1 (en)	2001-04-24
ZA923942B (en)	1993-11-29
AU1990192A (en)	1993-01-08
JPH0733386B2 (ja)	1995-04-12
SK390692A3 (en)	1998-02-04
US5807867A (en)	1998-09-15
ES2084361T3 (es)	1996-05-01
ATE135006T1 (de)	1996-03-15
RU2103269C1 (ru)	1998-01-27
CA2102179C (en)	1998-10-27
IE921729A1 (en)	1992-12-02
MA22539A1 (fr)	1992-12-31
NO2007003I2 (no)	2011-04-18
FI935297A (fi)	1993-11-29
DE9290063U1 (de)	1994-02-24
IL102008A (en)	1995-12-08
JPH06504292A (ja)	1994-05-19
NZ270673A (en)	1997-07-27
FI935297A0 (fi)	1993-11-29
NO934312L (no)	1993-11-29
NO302701B1 (no)	1998-04-14
IS3871A (is)	1992-12-02
BR9206073A (pt)	1994-12-06
HU217548B (hu)	2000-02-28
HUT70151A (en)	1995-09-28
MX9202554A (es)	1992-11-01
CZ281403B6 (cs)	1996-09-11
IS1611B (is)	1996-10-18
EP0587723B1 (de)	1996-03-06
CN1067428A (zh)	1992-12-30
SK278788B6 (sk)	1998-02-04
DK0587723T3 (da)	1996-04-01
NL300250I1 (nl)	2007-02-01
IL102008A0 (en)	1992-12-30
NL300250I2 (nl)	2007-03-01
NZ242956A (en)	1995-06-27
GR3019687T3 (en)	1996-07-31
CZ390692A3 (en)	1994-02-16
PT100546B (pt)	1999-12-31
UY23422A1 (es)	1992-11-12
GT199200028A (es)	1993-11-20
BG61694B1 (bg)	1998-03-31
PL171379B1 (en)	1997-04-30
NO934312D0 (no)	1993-11-29
FI114475B (fi)	2004-10-29
RO110499B1 (ro)	1996-01-30
WO1992021677A1 (en)	1992-12-10
KR100214905B1 (ko)	1999-08-02
YU48995B (sh)	2003-04-30

Publication	Publication Date	Title
DK0587723T3 (da)	1996-04-01	Quinuclidinderivater
NO922182D0 (no)	1992-06-02	Krystallinske oksatiolan-derivater
FI920718A (fi)	1992-08-21	Vaetskefoerdelare med indraget foerdelningsmunstycke
NO924890D0 (no)	1992-12-17	Imidazopyridiner
FI925763A (fi)	1993-06-21	Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
TR26336A (tr)	1995-03-15	SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
FI920440A (fi)	1992-09-12	Squid-maetningsanordning foersedd med skyddsorgan
FI912993A0 (fi)	1991-06-19	Teline
DE69222599D1 (de)	1997-11-13	Cephalosporin-Derivate
NO920420D0 (no)	1992-01-31	3-quinuklidin-derivater
DE59207540D1 (de)	1997-01-02	Resolver
FI88322B (fi)	1993-01-15	Med ledbommar foersedd arbetsmaskin
FI925469A (fi)	1993-06-04	Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
MX9206710A (es)	1993-05-01	Derivados de piridinol
FI921921A (fi)	1993-01-10	Hydrocyklonseparator med turbulensskydd
FI922274A (fi)	1992-11-24	Med slaeckningsgas fungerande flerstaellningsvridstaellare
FI912080A (fi)	1992-09-07	Lagringslaoda foersedd med en gavelvaeggen slutande genomsynlig klaffskiva
FI920393A (fi)	1992-11-28	Radio- och landfoerbindelsetelefoner med hands-free-funktion
FI921597A (fi)	1992-12-04	Maetning av en hisskorgs position med hjaelp av ultraljud
FI920834A (fi)	1992-08-28	Med fukos maerkta cytostater
DE69211197T2 (de)	1997-01-30	1-Hydroxyvitamin D-Derivate
KR930702353A (ko)	1993-09-08	2- 카르바페넴 유도체
FI920953A (fi)	1992-09-26	Belaeggningskopp med tvao ingaongar foer fiberbandkabel
FI922041A (fi)	1992-11-08	Planprodukt med perforerade kantfoerstaerkningsband
DE69227554T2 (de)	1999-07-15	Indolinospirobenzopyran-derivate